Market Closed -
NSE India S.E.
07:43:48 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
4,194
INR
|
+1.22%
|
|
+1.54%
|
-1.76%
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
152,157
|
184,043
|
207,004
|
198,918
|
158,614
|
191,852
|
-
|
-
|
Enterprise Value (EV)
1 |
152,157
|
184,043
|
207,004
|
198,918
|
158,614
|
191,852
|
191,852
|
191,852
|
P/E ratio
|
35.5
x
|
36.2
x
|
41.6
x
|
32.5
x
|
25.4
x
|
38.2
x
|
32.7
x
|
28.2
x
|
Yield
|
0.68%
|
0.25%
|
0.77%
|
0.8%
|
1.01%
|
1.22%
|
1.12%
|
1.34%
|
Capitalization / Revenue
|
7.31
x
|
8.55
x
|
9.25
x
|
7.62
x
|
6.54
x
|
8.72
x
|
8.06
x
|
7.29
x
|
EV / Revenue
|
7.31
x
|
8.55
x
|
9.25
x
|
7.62
x
|
6.54
x
|
8.72
x
|
8.06
x
|
7.29
x
|
EV / EBITDA
|
26.9
x
|
32.1
x
|
29.1
x
|
23.8
x
|
19.6
x
|
31.8
x
|
26.7
x
|
23.2
x
|
EV / FCF
|
163
x
|
60.1
x
|
50.5
x
|
23.8
x
|
54.6
x
|
38.2
x
|
41.4
x
|
39.1
x
|
FCF Yield
|
0.61%
|
1.66%
|
1.98%
|
4.19%
|
1.83%
|
2.62%
|
2.41%
|
2.55%
|
Price to Book
|
5.05
x
|
5.42
x
|
8.65
x
|
6.94
x
|
4.95
x
|
5.44
x
|
4.94
x
|
4.46
x
|
Nbr of stocks (in thousands)
|
45,748
|
45,748
|
45,748
|
45,748
|
45,748
|
45,748
|
-
|
-
|
Reference price
2 |
3,326
|
4,023
|
4,525
|
4,348
|
3,467
|
4,194
|
4,194
|
4,194
|
Announcement Date
|
5/28/19
|
6/15/20
|
5/26/21
|
5/20/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
20,815
|
21,516
|
22,386
|
26,110
|
24,248
|
22,007
|
23,806
|
26,332
|
EBITDA
1 |
5,652
|
5,726
|
7,121
|
8,357
|
8,089
|
6,038
|
7,189
|
8,270
|
EBIT
1 |
4,938
|
4,693
|
6,027
|
7,207
|
7,034
|
5,834
|
6,925
|
8,026
|
Operating Margin
|
23.72%
|
21.81%
|
26.92%
|
27.6%
|
29.01%
|
26.51%
|
29.09%
|
30.48%
|
Earnings before Tax (EBT)
1 |
6,599
|
6,425
|
6,687
|
7,729
|
8,240
|
6,696
|
7,837
|
9,071
|
Net income
1 |
4,290
|
5,091
|
4,976
|
6,126
|
6,239
|
5,015
|
5,878
|
6,803
|
Net margin
|
20.61%
|
23.66%
|
22.23%
|
23.46%
|
25.73%
|
22.79%
|
24.69%
|
25.84%
|
EPS
2 |
93.78
|
111.3
|
108.8
|
133.9
|
136.4
|
109.7
|
128.4
|
148.7
|
Free Cash Flow
1 |
933.2
|
3,063
|
4,096
|
8,343
|
2,907
|
5,028
|
4,631
|
4,901
|
FCF margin
|
4.48%
|
14.24%
|
18.3%
|
31.95%
|
11.99%
|
22.85%
|
19.45%
|
18.61%
|
FCF Conversion (EBITDA)
|
16.51%
|
53.5%
|
57.52%
|
99.83%
|
35.94%
|
83.28%
|
64.42%
|
59.26%
|
FCF Conversion (Net income)
|
21.75%
|
60.16%
|
82.32%
|
136.2%
|
46.59%
|
100.26%
|
78.79%
|
72.04%
|
Dividend per Share
2 |
22.50
|
10.00
|
35.00
|
35.00
|
35.00
|
51.03
|
47.13
|
56.20
|
Announcement Date
|
5/28/19
|
6/15/20
|
5/26/21
|
5/20/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
5,935
|
5,348
|
7,492
|
6,363
|
6,759
|
5,497
|
5,929
|
6,375
|
6,218
|
5,726
|
5,314
|
5,786
|
6,031
|
5,526
|
EBITDA
1 |
1,968
|
1,257
|
2,857
|
1,894
|
1,952
|
1,654
|
1,918
|
2,317
|
2,034
|
1,819
|
1,107
|
1,560
|
1,841
|
1,622
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
1,412
|
1,006
|
1,999
|
1,430
|
1,439
|
1,258
|
325.5
|
3,111
|
-
|
1,296
|
935.3
|
1,200
|
1,458
|
1,352
|
Net margin
|
23.8%
|
18.8%
|
26.68%
|
22.47%
|
21.29%
|
22.89%
|
5.49%
|
48.8%
|
-
|
22.64%
|
17.6%
|
20.75%
|
24.17%
|
24.47%
|
EPS
|
-
|
21.98
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
32.80
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/5/21
|
5/26/21
|
7/28/21
|
11/3/21
|
2/3/22
|
5/20/22
|
8/5/22
|
11/11/22
|
2/9/23
|
5/15/23
|
8/11/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
933
|
3,063
|
4,096
|
8,343
|
2,907
|
5,028
|
4,631
|
4,901
|
ROE (net income / shareholders' equity)
|
15.1%
|
15.9%
|
17.2%
|
23.3%
|
20.6%
|
14.8%
|
15.9%
|
16.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
658.0
|
742.0
|
523.0
|
626.0
|
701.0
|
770.0
|
848.0
|
941.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
44.9
|
18.2
|
177
|
153
|
650
|
250
|
339
|
346
|
Capex / Sales
|
0.22%
|
0.08%
|
0.79%
|
0.59%
|
2.68%
|
1.14%
|
1.42%
|
1.31%
|
Announcement Date
|
5/28/19
|
6/15/20
|
5/26/21
|
5/20/22
|
5/15/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -1.76% | 2.3B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|